DE69124705D1 - Hexapeptide als liganden des anaphylatoxin-rezeptors - Google Patents

Hexapeptide als liganden des anaphylatoxin-rezeptors

Info

Publication number
DE69124705D1
DE69124705D1 DE69124705T DE69124705T DE69124705D1 DE 69124705 D1 DE69124705 D1 DE 69124705D1 DE 69124705 T DE69124705 T DE 69124705T DE 69124705 T DE69124705 T DE 69124705T DE 69124705 D1 DE69124705 D1 DE 69124705D1
Authority
DE
Germany
Prior art keywords
ligands
hexapeptides
anaphylatoxin
anaphylatoxin receptor
oligopeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69124705T
Other languages
English (en)
Inventor
Paul E Wiedeman
Megumi Kawai
Jay Luly
Yat OR
Rolf Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69124705D1 publication Critical patent/DE69124705D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69124705T 1990-12-27 1991-12-10 Hexapeptide als liganden des anaphylatoxin-rezeptors Expired - Lifetime DE69124705D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/634,641 US5386011A (en) 1990-12-27 1990-12-27 Hexapeptide anaphylatoxin-receptor ligands
PCT/US1991/009319 WO1992011858A1 (en) 1990-12-27 1991-12-10 Hexa- and heptapeptide anaphylatoxin-receptor ligands

Publications (1)

Publication Number Publication Date
DE69124705D1 true DE69124705D1 (de) 1997-03-27

Family

ID=24544639

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69124705T Expired - Lifetime DE69124705D1 (de) 1990-12-27 1991-12-10 Hexapeptide als liganden des anaphylatoxin-rezeptors

Country Status (9)

Country Link
US (1) US5386011A (de)
EP (1) EP0564588B1 (de)
JP (1) JPH06504055A (de)
AT (1) ATE148891T1 (de)
CA (1) CA2095359A1 (de)
DE (1) DE69124705D1 (de)
IE (1) IE914398A1 (de)
PT (1) PT99940A (de)
WO (1) WO1992011858A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776892A (en) * 1990-12-21 1998-07-07 Curative Health Services, Inc. Anti-inflammatory peptides
US5387671A (en) * 1990-12-27 1995-02-07 Abbott Laboratories Hexa- and heptapeptide anaphylatoxin-receptor ligands
US5807824A (en) * 1993-12-06 1998-09-15 Ciba-Geigy Corporation C5A receptor antagonists having substantially no agonist activity
US5837499A (en) * 1993-12-06 1998-11-17 Ciba-Geigy Corporation DNA encoding C5A receptor antagonists having substantially no agonist activity and methods of expressing same
US5614370A (en) * 1994-03-18 1997-03-25 Merck & Co., Inc. Assay to identify human C5a antagonists and agonists
GB9617021D0 (en) 1996-08-13 1996-09-25 Salpep Biotechnology Inc Novel peptides for treatment of inflammation and shock
AUPO755097A0 (en) * 1997-06-25 1997-07-17 University Of Queensland, The Receptor agonist and antagonist
US6011006A (en) * 1998-03-05 2000-01-04 Novo Nordisk A/S Method of treating hot flushes with hexapeptides
DE19838360A1 (de) * 1998-04-22 1999-10-28 Biotronik Mess & Therapieg Gefäßelektrodenleitung
AU5667900A (en) 1999-06-30 2001-01-22 Prescient Neuropharma Inc. 2-aminoindane analogs
EP1739078A1 (de) 2005-05-30 2007-01-03 Jerini AG C5a-Rezeptor-Antagonisten
US7407922B2 (en) * 2005-10-13 2008-08-05 S.C. Johnson & Son, Inc. Deodorizing compositions
US7261742B2 (en) 2005-10-13 2007-08-28 S.C. Johnson & Son, Inc. Method of deodorizing a textile
US10758636B2 (en) 2013-11-12 2020-09-01 Centre For Probe Development And Commercialization Residualizing linkers and uses thereof
IL313115A (en) 2017-05-05 2024-07-01 Centre For Probe Dev And Commercialization R1–IGF monoclonal antibodies and their use
JP2020518673A (ja) 2017-05-05 2020-06-25 フュージョン・ファーマシューティカルズ・インコーポレイテッド 二官能性キレートの薬物動態増強及びその使用
US10093741B1 (en) 2017-05-05 2018-10-09 Fusion Pharmaceuticals Inc. IGF-1R monoclonal antibodies and uses thereof
AU2018284219A1 (en) * 2017-06-12 2020-01-16 Board Of Regents Of The University Of Nebraska Hydrochloride salts of C5a receptor agonist peptides
WO2019201432A1 (en) * 2018-04-17 2019-10-24 Zedira Gmbh Inhibitors of blood coagulation factor xiii

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0305615A1 (de) * 1987-09-03 1989-03-08 Immunetech Pharmaceuticals, Inc. Peptidantagonisten für C5a-Anaphylotoxin
WO1990009162A2 (en) * 1989-01-31 1990-08-23 Abbott Laboratories Anaphylatoxin-receptor ligands
US5387671A (en) * 1990-12-27 1995-02-07 Abbott Laboratories Hexa- and heptapeptide anaphylatoxin-receptor ligands

Also Published As

Publication number Publication date
PT99940A (pt) 1993-01-29
EP0564588A1 (de) 1993-10-13
JPH06504055A (ja) 1994-05-12
ATE148891T1 (de) 1997-02-15
US5386011A (en) 1995-01-31
IE914398A1 (en) 1992-07-01
WO1992011858A1 (en) 1992-07-23
CA2095359A1 (en) 1992-06-28
EP0564588A4 (en) 1993-12-29
EP0564588B1 (de) 1997-02-12

Similar Documents

Publication Publication Date Title
DE69124705D1 (de) Hexapeptide als liganden des anaphylatoxin-rezeptors
WO1990009162A3 (en) Anaphylatoxin-receptor ligands
DE69109560D1 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
DK0916348T3 (da) Alkyldextranpolyalkohollægemiddelkomplekser
DE69807074D1 (de) Substituierte 1,2,4-triazolo[3,4,-a]phthalazin-derivate als gaba-alpha 5-liganden
TR200200068T2 (tr) Nematisital triflüorobütenler
DE69021920D1 (de) Behandlung von Textilien mit Parfüm/Cyclodextrin-Komplexen.
ATE29128T1 (de) Reinigungsmittel und zusammensetzungen daraus.
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
DE69841866D1 (de) Verwendung von MHC Klasse II Liganden (CD4 und LAG-3) als Adjuvans für Impfungen und von LAG-3 bei Behandlung von Krebs
DE69109401D1 (de) Wässrige Zusammensetzungen zur Behandlung von porösen Substraten.
DE69600983D1 (de) Kapselpräparate zur Behandlung von Pflanzen
ATE196083T1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
DE69110713D1 (de) 7-Oxabicycloheptan-imidazol-prostaglandin-Analoge, verwendbar bei der Behandlung von thrombotischen und vasospastischen Erkrankungen.
ATE203416T1 (de) Schwermetallcluster zur verwendung als abbildungsmittel
NO981393D0 (no) Guanidinoproteasehemmere
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
DE69133144D1 (de) Reaktor zur Behandlung von Wafern
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
ATE181240T1 (de) Verwendung von somatostatinanalogen zur behandlung von melanomen
DE69129070D1 (de) Behandlung von tumorogenen pathophysiologischen zuständen durch verwendung von f4f-cytotoxinkonjugaten
DE69408394D1 (de) 4-Piperidino-piperidin zur Behandlung von Tumoren
ATE174035T1 (de) Neue tetrapeptide, ihre herstellung und verwendung
MX9305731A (es) Compuestos organicos de oligopeptidos o analogos de oligopeptidos que son ligandos para el receptor de anafilatoxina y composiciones farmaceuticas que los contienen.
DE68908445D1 (de) Mittel zur behandlung von lebererkrankungen.

Legal Events

Date Code Title Description
8332 No legal effect for de